SCN1A and glioblastoma: Understanding the interplay between SCN1A and its corresponding β subunits in GBM could provide deeper insights into the molecular mechanisms underlying GBM stemness, invasion, and resistance to TMZ, potentially unveiling novel therapeutic targets.